XTL Biopharma (XTLB) Reports Q1 Loss of $0.01/Share
Tweet
Share
E-mailGet Alerts XTLB Hot Sheet
Join SI Premium – FREE
XTL Biopharma (NASDAQ: XTLB) reported Q1 EPS of ($0.01), versus $0.00 reported last year.
For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
- Innovaro (INV) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
